Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression
Open Access
- 1 January 1997
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 99 (1) , 28-37
- https://doi.org/10.1016/s0091-6749(97)70297-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Preferential recruitment of activated, memory T lymphocytes into skin chamber fluids during human cutaneous late-phase allergic reactionsJournal of Allergy and Clinical Immunology, 1995
- Association of Protein Kinase A and Protein Phosphatase 2B with a Common Anchoring ProteinScience, 1995
- Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 1993
- Increased Interleukin-4 Production by Atopic Mononuclear Leukocytes Correlates with Increased Cyclic Adenosine Monophosphate – Phosphodiesterase Activity and Is Reversible by Phosphodiesterase InhibitionJournal of Investigative Dermatology, 1993
- The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cellsInternational Journal of Immunopharmacology, 1993
- Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cellsInflammation Research, 1993
- Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsInflammation Research, 1993
- Synergistic Effects of Interleukin 4 and Interferon-Gamma on Monocyte Phosphodiesterase ActivityJournal of Investigative Dermatology, 1992
- Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsivenessJournal of Allergy and Clinical Immunology, 1982
- Modulation of Inflammation and Immunity by Cyclic AMPScience, 1974